IE
GOSS icon

Israel Englander’s Gossamer Bio GOSS Stock Holding History

Israel Englander’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-215,000
Closed -$1.87M – 7161
2022
Q1 		$1.87M Buy
+215,000
New +$2.07M ﹤0.01% 3952
2020
Q4 		– Sell
-120,000
Closed -$1.49K – 5341
2020
Q3 		$1.49K Buy
120,000
+110,000
+1,100% +$1.46M ﹤0.01% 2827
2020
Q2 		$130K Hold
10,000
– – ﹤0.01% 3937
2020
Q1 		$102K Buy
+10,000
New +$131K ﹤0.01% 3547

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Israel Englander's GOSS Position: Q2 2026 in Review

Israel Englander increased its Gossamer Bio (GOSS) stake by 1,182% in Q2 2026, buying an estimated $618K and bringing the position to 2,402,633 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #4941.

Israel Englander first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $15.9M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Israel Englander held 2,402,633 shares of Gossamer Bio worth $395K as of Q2 2026.
  • Israel Englander bought 2,215,215 Gossamer Bio shares in Q2 2026, an estimated $618K.
  • Gossamer Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4941 holding.
  • Israel Englander first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
  • Israel Englander's Gossamer Bio position peaked at $15.9M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.